RT Journal Article
T1 Recent developments and highlights in drug hypersensitivity.
A1 Mayorga, Cristobalina
A1 Fernandez, Tahia D
A1 Montañez, Maria Isabel
A1 Moreno, Esther
A1 Torres, María José
K1 allergy diagnosis
K1 allergy treatment
K1 basic mechanisms
K1 drug allergy
K1 epidemiology
AB Drug hypersensitivity reactions (DHRs) are nowadays the third cause of allergy after rhinitis and asthma with a significant increase in prevalence in both adults and paediatric population with new drugs included as culprit. For this, DHRs represent not only a health problem but also a significant financial burden for affected individuals and health systems. Mislabelling DHRs is showing to be a relevant problem for both, false label of drug allergic and false label of nonallergic. All this reinforces the need to improve accurate diagnostic approaches that allow an appropriate management. Moreover, there is a need for training both, nonallergist stakeholders and patients to improve the reaction identification and therefore decrease the mislabelling. The use of allergy cards has shown to be relevant to avoid the induction of DHRs due to the prescription of wrong medication. Recent developments over the last 2 years and highlights about risk factors, diagnostic approaches, mechanisms involved as well as prevention actions, and management have been reviewed. In these papers, it has been outlined the need for correct diagnosis and de-labelling of patients previously false-reported as allergic, which will improve the management and treatment of patients with DHRs.
YR 2019
FD 2019-10-23
LK http://hdl.handle.net/10668/14551
UL http://hdl.handle.net/10668/14551
LA en
DS RISalud
RD Apr 10, 2025